Picture supply: Getty Photos
British buyers are spoilt for alternative as a result of they’ve two methods of investing in a tax-efficient means, both in a Self-Invested Private Pension (SIPP) or a Shares and Shares ISA. So spoilt, in reality, that many battle to determine which to make use of.
Each supply engaging however markedly completely different tax breaks. I made a decision to name in assist from ChatGPT, and requested it whether or not somebody with £20,000 to spend money on 2026 can be higher off with a SIPP or ISA.
Please word that tax therapy will depend on the person circumstances of every consumer and could also be topic to vary in future. The content material on this article is supplied for data functions solely. It’s not supposed to be, neither does it represent, any type of tax recommendation. Readers are liable for finishing up their very own due diligence and for acquiring skilled recommendation earlier than making any funding selections.
Tax-efficient investing
I’d by no means use synthetic intelligance to select shares or populate a portfolio. That’s not what it’s for. However I assumed it ought to be moderately competent on technical questions like this. So which tax shelter does the heavy lifting?
ChatGPT went straight to the massive attraction of a SIPP, beneficiant tax reduction on contributions. A basic-rate 20% taxpayer solely must contribute £16,000 to finish up with £20,000 invested, whereas 40% higher-rate taxpayers can reclaim one other £4,000 by means of their tax return. That’s a robust begin.
The trade-off is entry. Pension cash is locked away till not less than age 55, rising to 57 from 2028. At retirement, 25% will be taken tax-free, however the remainder shall be taxed as revenue.
There’s no tax reduction when investing in a Shares and Shares ISA, however tax-free withdrawals will be made at any age. Each wrappers shelter investments from dividend tax and capital good points tax, serving to wealth compound.
ChatGPT ran by means of the choices properly, however then I intervened. To me, I believe the tax breakes complement one another so properly, it may make sense to make use of them each. That means buyers get tax reduction on half their contributions, because of the SIPP, and might take half their returns freed from tax, courtesy of the Shares and Shares ISA.
GSK shares tempt me
AI positively isn’t for inventory selecting, as ChatGPT is first to confess. So this bit is me. Proper now, I believe buyers — whether or not utilizing a SIPP or an ISA — may like to contemplate FTSE 100 prescribed drugs big GSK (LSE: GSK). After years of frustration, GSK lastly got here good in 2025, with the shares ending roughly 38% greater. The trailing dividend yield of three.35% is forecast to hit 3.9% in 2026.
Regardless of the restoration, the valuation nonetheless appears to be like cheap. The worth-to-earnings ratio sits at 11.4. That’s not demanding for a world healthcare group with an extended historical past and defensive qualities.
A lot will depend on what’s already within the portfolio. Anybody closely uncovered to prescribed drugs by means of rival AstraZeneca might determine to cross. For these with out healthcare publicity, GSK may add stability and diversification.
Dangers and resilience
There are dangers. Former chief government Emma Walmsley set formidable income targets for 2030, which can be robust to achieve. A number of key HIV patents expire in 2028 and 2029, and US vaccination coverage stays unsure.
Nonetheless, confidence is bettering. In February 2025, GSK introduced its first share buyback since 2013, price £2bn. With a broad pipeline and reliable revenue, buyers may contemplate shopping for as a part of a long-term, diversified portfolio.
No single share is ideal, simply as no single tax wrapper does every thing. Traders ought to construct a balanced portfolio of not less than a dozen shares, and do their very own analysis, reasonably than counting on AI.
